News Hub

Real-time financial, economic, and global news with market-focused context and analysis.

Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.

  • President Trump ordered an immediate U.S. naval blockade of the Strait of Hormuz and vowed to interdict vessels paying Iran tolls, boosting oil-market risk.
  • Artemis II crew completed a successful splashdown, validating Orion heat-shield and recovery procedures and supporting aerospace contractor sentiment.
  • GSK reported early Mo-rez tumor shrinkage, with executives calling the asset a potential blockbuster for the company's oncology pipeline.
  • Credo fell after earnings despite blowout revenue and margins, creating a tactical buy window for momentum traders.
  • Analysts recommended a tactical long in UnitedHealth, citing Medicare Advantage rate tailwinds and Optum efficiency gains despite regulatory overhang.
  • Capital One is at an inflection; analysts advise a Hold while watching integration execution and rising credit signals.
  • CoreWeave triggered buy signals after multi-year deals and fresh financing, offering upside amid valuation and execution risk.

Latest Articles

Copenhagen Stocks Slide; OMX Copenhagen 20 Drops 2.12% to Five-Year Low

Copenhagen Stocks Slide; OMX Copenhagen 20 Drops 2.12% to Five-Year Low

Denmark's equity market closed lower on Friday, with the benchmark OMX Copenhagen 20 tumbling 2.12% to reach a new five-year low. Losses were concentrated in the Healthcare, Financials and Chemicals sectors, while market breadth skewed heavily toward decliners. Several blue chips recorded significant moves, with Novo Nordisk hitting multi-year lows…

Dollar Climbs to 160 Yen as Tokyo's Intervention Threshold Looms

Dollar Climbs to 160 Yen as Tokyo's Intervention Threshold Looms

The U.S. dollar strengthened to roughly 160 yen on Friday, a level traders view as a potential trigger for official action by Japanese authorities. The move accompanies gains in the dollar index as investors seek U.S. currency amid geopolitical uncertainty, while Japan's fiscal policy stance and reliance on energy imports leave the yen and local go…

RENN Fund President Purchases 1,134 RCG Shares in Late-March Trade

RENN Fund President Purchases 1,134 RCG Shares in Late-March Trade

Murray Stahl, president and co-portfolio manager of RENN Fund, acquired 1,134 shares of RENN Fund, Inc. (RCG) on March 26, 2026, at $3.29 per share, increasing his direct holdings to 158,174 shares. The transaction totaled $3,730 and occurs while RCG shares have risen 28% over the prior six months and sit near their 52-week high, according to Inves…

Citigroup Stock Drops After Report of Talks to Buy Regional Bank

Citigroup Stock Drops After Report of Talks to Buy Regional Bank

Citigroup Inc. (NYSE:C) shares fell about 4% on Friday following a report that the bank’s senior management has held early conversations about buying a regional lender to shore up deposits that could support its lending and trading businesses. The talks were described as preliminary, and Citigroup has denied that it is planning acquisitions. Any de…

Lumentum: Photonics Momentum Beyond AI - A Tactical Long

Lumentum: Photonics Momentum Beyond AI - A Tactical Long

Lumentum's products power the data center 'nervous system' and recent strategic endorsements (including a $2B partner push) plus S&P inclusion have re-rated the stock. The business shows rapid top-line growth and improving profitability, but multiples are rich and execution and macro risks remain. This is a tactical long for active traders looking …

LB Pharmaceuticals Presents New Analysis from the Phase 2 NOVA-1 Trial Highlighting LB-102’s Potential Impact on Cognitive Performance at the 2026 Annual Congress of the Schizophrenia International Research Society (SIRS)

LB Pharmaceuticals Presents New Analysis from the Phase 2 NOVA-1 Trial Highlighting LB-102’s Potential Impact on Cognitive Performance at the 2026 Annual Congress of the Schizophrenia International Research Society (SIRS)

LB Pharmaceuticals announced new positive data from the Phase 2 NOVA-1 trial showing that LB-102, a novel benzamide antipsychotic candidate, directly improves cognitive performance in patients with acute schizophrenia. These findings, presented at the 2026 Schizophrenia International Research Society Congress, support ongoing Phase 3 and additional…

Tel Aviv Stocks Slide; TA-35 Drops 3.79% to One-Month Low

Tel Aviv Stocks Slide; TA-35 Drops 3.79% to One-Month Low

Israel's main equity gauge ended lower after the close on Friday, with the TA-35 index plunging 3.79% to a fresh one-month low. Losses were concentrated in the Insurance, Technology and Financials sectors. Market breadth was weak, with decliners far outnumbering advancers. Commodity and currency markets saw notable moves at the same time.

Iran Signals Written Reply to U.S. Peace Offer Is Expected Friday

Iran Signals Written Reply to U.S. Peace Offer Is Expected Friday

A source briefed on discussions said Iran is expected to deliver a written counter-proposal on Friday in response to a 15-point U.S. peace plan. The plan, routed via Pakistan, contained demands ranging from dismantling Iran's nuclear program to curbs on its missile work and control over the Strait of Hormuz. Iranian officials have reviewed the prop…

CVC Weighs Asset Sales as Part of Proposed Recordati Takeover

CVC Weighs Asset Sales as Part of Proposed Recordati Takeover

CVC Capital Partners is evaluating a range of options for Recordati should its €10.9 billion takeover proposal be finalized, including the possible sale of the drugmaker's rare-diseases business. The approach values Recordati at €52 a share including dividend and represents a 12% premium to the stock's last closing price prior to the offer.

Perma-Fix Looks Poised For A Strong H2 '26 - Tactical Long Setup

Perma-Fix Looks Poised For A Strong H2 '26 - Tactical Long Setup

Perma-Fix (PESI) has a credible path to outsized H2 2026 revenue and margin improvement driven by nuclear waste volumes, recent pilot success on PFAS destruction, and new government contract access. The balance sheet is manageable, and the stock sits near an oversold technical footprint with short interest elevated - set up a disciplined long with …

Casablanca stocks retreat as utilities, banks and miners weigh on market

Casablanca stocks retreat as utilities, banks and miners weigh on market

Morocco's stock market finished lower on Friday, with the Moroccan All Shares index falling 1.27%. Losses were concentrated in the Utilities, Banking and Mining sectors. Market breadth favored decliners, and global commodity prices for crude oil and gold advanced during the session. Major FX pairs against the Moroccan dirham showed little movement.

First BanCorp (FBP) — Buy the Dip; Fundamentals Still Intact

First BanCorp (FBP) — Buy the Dip; Fundamentals Still Intact

First BanCorp (FBP) looks oversold on headlines and positioning risk, but the bank's underlying metrics - low leverage, double-digit ROE, healthy free cash flow and a 3.5% yield - argue against an outright downgrade trade. This is a mid-term swing long with a clear entry, stop and target and a cautious risk plan if macro or asset-quality data deter…